Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,128 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Limitations of acyclovir and identification of potent HSV antivirals using 3D bioprinted human skin equivalents.
Ellison ST, Hayman I, Derr K, Derr P, Frebert S, Itkin Z, Shen M, Jones A, Olson W, Corey L, Wald A, Johnston C, Fong Y, Ferrer M, Zhu J. Ellison ST, et al. Among authors: corey l. bioRxiv [Preprint]. 2025 Jun 21:2024.12.04.626896. doi: 10.1101/2024.12.04.626896. bioRxiv. 2025. Update in: Nat Commun. 2025 Oct 16;16(1):9200. doi: 10.1038/s41467-025-64245-w. PMID: 39713402 Free PMC article. Updated. Preprint.
Expansion of the HSV-2-specific T cell repertoire in skin after immunotherapeutic HSV-2 vaccine.
Ford ES, Li A, Laing KJ, Dong L, Diem K, Jing L, Basu K, Ott M, Tartaglia J, Gurunathan S, Reid JL, Ecsedi M, Chapuis AG, Huang ML, Magaret AS, Johnston C, Zhu J, Koelle DM, Corey L. Ford ES, et al. Among authors: corey l. medRxiv [Preprint]. 2024 Feb 1:2022.02.04.22270210. doi: 10.1101/2022.02.04.22270210. medRxiv. 2024. Update in: JCI Insight. 2024 Jun 18;9(14):e179010. doi: 10.1172/jci.insight.179010. PMID: 38352384 Free PMC article. Updated. Preprint.
Impact of prior SARS-CoV-2 acquisition on binding and neutralizing antibody responses following COVID-19 vaccination: A cross-protocol analysis of individual-level data from six phase 3 clinical trials.
Hudson A, Borgetti S, Rick AM, Laurens MB, Robinson ST, Gay CL, Baden LR, Goepfert PA, Rouphael N, El Sahly HM, Gray GE, Grinsztejn B, Sobieszczyk ME, Falsey AR, Huang Y, Janes H, Follmann D, Koup RA, Priddy F, Hendriks J, Shoemaker K, Dunkle LM, de Bruyn G, Devlin L, Neuzil KM, Kublin JG, Corey L, Walsh SR, Kotloff KL, Gilbert PB. Hudson A, et al. Among authors: corey l. Vaccine. 2026 Feb 22;77:128380. doi: 10.1016/j.vaccine.2026.128380. Online ahead of print. Vaccine. 2026. PMID: 41730823 Free article.
Association between COVID-19 vaccine efficacy and epidemic force of infection.
Xu J, Halloran ME, Moore M, Zhang L, Hyrien O, Luedtke A, El Sahly HM, Baden LR, Goepfert PA, Gray G, Grinsztejn B, Sobieszczyk ME, Falsey AR, Robinson ST, Garcia NMG, Zhou H, van Dromme I, Truyers C, Hirsch I, Neuzil KM, Corey L, Kublin JG, Follmann D, Janes HE, Gilbert PB, Huang Y. Xu J, et al. Among authors: corey l. NPJ Vaccines. 2026 Jan 17;11(1):54. doi: 10.1038/s41541-026-01374-3. NPJ Vaccines. 2026. PMID: 41547989 Free PMC article.
Efficacy and safety of a mosaic HIV-1 vaccine regimen in men who have sex with men and transgender individuals (HVTN 706/HPX3002/Mosaico): a global, randomised, double-blind, placebo-controlled, phase 3 trial.
Buchbinder SP, Spinosa Guzman S, Sanchez J, Willems W, Stieh DJ, van Duijn J, van Rosmalen MGM, Hendriks J, Nijs S, Lavreys L, Paez CA, Grinzstejn B, Hutter J, Mann P, Sierra Madero JG, Cahn P, Castagna A, Truyers C, Roels S, Gilbert PB, Carone M, Luedtke A, Corey L, Pau MG, Tomaka F; HVTN 706/HPX3002/Mosaico Study Team. Buchbinder SP, et al. Among authors: corey l. Lancet HIV. 2025 Dec;12(12):e823-e835. doi: 10.1016/S2352-3018(25)00195-X. Lancet HIV. 2025. PMID: 41314741 Clinical Trial.
Long-Read Deep Sequencing Reveals High Rates of Multilineage Transmission and Rapid Viral Population Changes in Acute HIV Infection.
Mullins JI, Deng W, Giorgi EE, Magaret CA, Rolland M, Bhattacharya T, Westfall DH, Yssel AEJ, Bumgarner RE, Murrell B, Ndung'u T, Robb ML, Rossenkhan R, Edlefsen PT, Dong KL, Chen L, Gwashu-Nyangiri A, Zhao H, Thebus R, Sawe F, Nitayaphan S, York T, Matten D, Murrell H, Pankow AP, Juraska M, Ludwig J, Hural J, Cohen MS, Corey L, McElrath MJ, Gilbert PB, Williamson C. Mullins JI, et al. Among authors: corey l. bioRxiv [Preprint]. 2025 Oct 15:2025.10.15.682663. doi: 10.1101/2025.10.15.682663. bioRxiv. 2025. PMID: 41279611 Free PMC article. Preprint.
VRC01 Selects Rare HIV Escape Mutations After Acquisition in Antibody-Mediated Prevention Trials.
Williamson C, Curry L, Mkhize NN, Giorgi EE, Magaret CA, Lambson BE, Hons SB, Kaldine H, Moyo-Gwete T, Rolland M, Rossenkhan R, Garcia NMG, Moodley C, Yssel A, Huang Y, Marsden AA, Reeves DB, Mayer BT, Bumgarner RE, Beaume N, Westfall DH, Juraska M, DeCamp AC, Murrell H, Bai H, Deng W, Pankow AP, Bhattacharya T, York T, Ndabambi N, Chen L, Zhao H, Gwashu-Nyangiri A, Thebus R, Cohen P, Murrell B, Karuna S, Hural J, Mgodi N, Edupuganti S, Morris L, Montefiori D, McElrath MJ, Cohen MS, Corey L, Edlefsen PT, Gilbert PB, Moore PL, Mullins JI. Williamson C, et al. Among authors: corey l. bioRxiv [Preprint]. 2025 Oct 29:2025.10.29.685411. doi: 10.1101/2025.10.29.685411. bioRxiv. 2025. PMID: 41279072 Free PMC article. Preprint.
Immune correlates analysis of antibody responses against SARS-CoV-2 variants in the ENSEMBLE vaccine efficacy trial.
Luedtke A, Fong Y, van der Laan L, Heng F, Huang Y, Lu Y, Yu C, Carpp LN, Roels S, Le Gars M, Van Roey GA, Stieh DJ, Van Dromme I, Kenny A, Carone M, Hyrien O, Ayala V, Jayashankar L, Castellino F, Amoa-Awua O, Basappa M, Flach B, Lin BC, Moore C, Naisan M, Naqvi M, Narpala S, O'Connell S, Mueller A, Serebryannyy L, Castro M, Wang J, Dziubla G, Randhawa AK, Andrasik MP, Hendriks J, Truyers C, Struyf F, Schuitemaker H, Douoguih M, Kublin JG, Corey L, Neuzil KM, Bekker LG, Garrett N, Cardoso SW, DelaFontaine P, Magaret CA, Vingerhoets J, Casapia M, Losso MH, Little SJ, Gaur A, Swann E, Petropoulos CJ, McDermott AB, Sadoff J, Gray GE, Grinsztejn B, Goepfert PA, Follmann D, Roychoudhury P, Greninger AL, Koup RA, Donis RO, Gilbert PB; Immune Assays Team; Coronavirus Vaccine Prevention Network (CoVPN)/ENSEMBLE Team; United States Government (USG)/CoVPN Biostatistics Team. Luedtke A, et al. Among authors: corey l. iScience. 2025 Sep 29;28(11):113660. doi: 10.1016/j.isci.2025.113660. eCollection 2025 Nov 21. iScience. 2025. PMID: 41210956 Free PMC article.
Vaccine induction of heterologous HIV-1-neutralizing antibody B cell lineages in humans.
Williams WB, Alam SM, Ofek G, Erdmann N, Montefiori DC, Seaman MS, Wagh K, Korber B, Edwards RJ, Mansouri K, Eaton A, Cain DW, Martin M, Hwang J, Arus-Altuz A, Lu X, Cai F, Jamieson N, Parks R, Barr M, Foulger A, Anasti K, Patel P, Sammour S, Parsons RJ, Huang X, Lindenberger J, Fetics S, Janowska K, Niyongabo A, Janus BM, Astavans A, Fox CB, Mohanty I, Evangelous T, Chen Y, Berry M, Kirshner H, Van Itallie E, Saunders KO, Wiehe K, Cohen KW, McElrath MJ, Corey L, Acharya P, Walsh SR, Baden LR, Haynes BF. Williams WB, et al. Among authors: corey l. Cell. 2025 Nov 13;188(23):6688-6689. doi: 10.1016/j.cell.2025.10.023. Epub 2025 Nov 1. Cell. 2025. PMID: 41177155 Free article. No abstract available.
1,128 results